SynthesisFrontiers in cardiovascular medicine2022

Effect of alirocumab and evolocumab on all-cause mortality and major cardiovascular events: A meta-analysis focusing on the number needed to treat.

Hong-Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.